Mechanism of Action: Xanthine Oxidase Inhibitors
Drugs with Mechanism of Action: Xanthine Oxidase Inhibitors
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms | ALLOPURINOL | allopurinol | TABLET;ORAL | 210117-001 | Oct 12, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hetero Labs Ltd V | ALLOPURINOL | allopurinol | TABLET;ORAL | 217748-001 | Aug 3, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Aurobindo Pharma Ltd | ALLOPURINOL | allopurinol | TABLET;ORAL | 215091-001 | Apr 14, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mylan | ALLOPURINOL | allopurinol | TABLET;ORAL | 018659-001 | Oct 24, 1986 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
